Dennis Wylie

Technologies

• First-in-class blood-based diagnostic panel for depression and suicide risk
• High-throughput RNA sequencing technology for comprehensive transcriptome profiling and biomarker identification in inflammatory breast cancer
• BRAIN-DERIVED SPECIFIC MOLECULAR AND CELL-TYPE RNA MARKERS FOR DIAGNOSING AND TREATING DEPRESSION